該雜志國際簡稱:JAMA ONCOL,是由出版商American Medical Association出版的一本致力于發(fā)布醫(yī)學(xué)研究新成果的的專業(yè)學(xué)術(shù)期刊。該雜志以O(shè)NCOLOGY研究為重點,主要發(fā)表刊登有創(chuàng)見的學(xué)術(shù)論文文章、行業(yè)最新科研成果,扼要報道階段性研究成果和重要研究工作的最新進展,選載對學(xué)科發(fā)展起指導(dǎo)作用的綜述與專論,促進學(xué)術(shù)發(fā)展,為廣大讀者服務(wù)。該刊是一本國際優(yōu)秀雜志,在國際上有很高的學(xué)術(shù)影響力。
Testing for EGFR Variants in Pleural and Pericardial Effusion Cell-free DNA in Patients With Non-Small Cell Lung Cancer
Author: Lee, Kirsty W. C.; Li, Molly S. C.; Gai, Wanxia; Lau, Yat Ming; Chan, Allen K. C.; Chan, Oscar S. H.; Lee, Chee Khoon; Yeung, Rebecca M. W.; Fung, Sherwood Y. H.; Cheung, Wai F. F.; Chan, Vivian W. W.; Leung, Linda; Kam, Kenny N. P.; Mok, Tony S. K.
Association of Immune-Related Adverse Events With Efficacy of Atezolizumab in Patients With Non-Small Cell Lung Cancer Pooled Analyses of the Phase 3 IMpower130, IMpower132, and IMpower150 Randomized Clinical Trials
Author: Socinski, Mark A.; Jotte, Robert M.; Cappuzzo, Federico; Nishio, Makoto; Mok, Tony S. K.; Reck, Martin; Finley, Gene G.; Kaul, Monika D.; Yu, Wei; Paranthaman, Nindhana; Bara, Ilze; West, Howard J.
Estimates and Projections of the Global Economic Cost of 29 Cancers in 204 Countries and Territories From 2020 to 2050
Anlotinib for Refractory Advanced Non-Small Cell Lung Cancer in China.
Author: Chen XZ1.
英文介紹
Jama Oncology雜志英文介紹
JAMA Oncology is an international peer-reviewed journal and the definitive journal for scientists, clinicians, and trainees in the field of oncology. JAMA Oncology is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications.